Bausch Health Companies Inc.
BHC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $3 |
| - Cash | $1 | $2 | $1 | $1 |
| + Debt | $21 | $22 | $22 | $22 |
| Enterprise Value | $22 | $22 | $23 | $23 |
| Revenue | $1 | $3 | $2 | $3 |
| % Growth | -64% | 12% | -11.7% | – |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 173.2% | 69.8% | 69% | 71.6% |
| EBITDA | $3 | $1 | $1 | $1 |
| % Margin | 276.3% | 30.2% | 26.6% | 35.2% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 19.6% | 5.8% | -2.6% | 3.6% |
| EPS Diluted | -0.24 | 0.4 | -0.16 | 0.25 |
| % Growth | -160% | 350% | -164% | – |
| Operating Cash Flow | $0 | $0 | $0 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |